Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.040
-0.030 (-1.45%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $30.59 million as of July 30, 2026. Its market cap has decreased by -48.54% in one year.
Market Cap
30.59M
Enterprise Value
9.41M
1-Year Change
-48.54%
Ranking
Category
Stock Price
$2.04
ChartMarket Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $30.59M, a decrease of -75.55%. That is a compound annual growth rate of -45.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 30.59M | 49.97% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enlivex | 36.00M |
| Nutriband | 35.92M |
| Veru Inc. | 35.79M |
| CervoMed | 34.63M |
| Lantern Pharma | 33.17M |
| Lite Strategy | 33.00M |
| Estrella Immunopharma | 32.21M |
| BriaCell Therapeutics | 31.07M |